The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug of Abuse (DOA) Testing Market Research Report 2024
Synopsis
The drug of abuse test is an immunoassay based on the principle of competitive binding.
The global Drug of Abuse (DOA) Testing market was valued at US$ 6321 million in 2023 and is anticipated to reach US$ 9703.7 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
This report aims to provide a comprehensive presentation of the global market for Drug of Abuse (DOA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug of Abuse (DOA) Testing.
Report Scope
The Drug of Abuse (DOA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug of Abuse (DOA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug of Abuse (DOA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Segment by Type
Urine
Saliva
Hair
Others
Segment by Application
Hospitals
Laboratories
Workplace
At-Home
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug of Abuse (DOA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The drug of abuse test is an immunoassay based on the principle of competitive binding.
The global Drug of Abuse (DOA) Testing market was valued at US$ 6321 million in 2023 and is anticipated to reach US$ 9703.7 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
This report aims to provide a comprehensive presentation of the global market for Drug of Abuse (DOA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug of Abuse (DOA) Testing.
Report Scope
The Drug of Abuse (DOA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug of Abuse (DOA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug of Abuse (DOA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Segment by Type
Urine
Saliva
Hair
Others
Segment by Application
Hospitals
Laboratories
Workplace
At-Home
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug of Abuse (DOA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Urine
1.2.3 Saliva
1.2.4 Hair
1.2.5 Others
1.3 Market by Application
1.3.1 Global Drug of Abuse (DOA) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Workplace
1.3.5 At-Home
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug of Abuse (DOA) Testing Market Perspective (2019-2030)
2.2 Drug of Abuse (DOA) Testing Growth Trends by Region
2.2.1 Global Drug of Abuse (DOA) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug of Abuse (DOA) Testing Historic Market Size by Region (2019-2024)
2.2.3 Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2025-2030)
2.3 Drug of Abuse (DOA) Testing Market Dynamics
2.3.1 Drug of Abuse (DOA) Testing Industry Trends
2.3.2 Drug of Abuse (DOA) Testing Market Drivers
2.3.3 Drug of Abuse (DOA) Testing Market Challenges
2.3.4 Drug of Abuse (DOA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue
3.1.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue (2019-2024)
3.1.2 Global Drug of Abuse (DOA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug of Abuse (DOA) Testing Revenue
3.4 Global Drug of Abuse (DOA) Testing Market Concentration Ratio
3.4.1 Global Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug of Abuse (DOA) Testing Revenue in 2023
3.5 Drug of Abuse (DOA) Testing Key Players Head office and Area Served
3.6 Key Players Drug of Abuse (DOA) Testing Product Solution and Service
3.7 Date of Enter into Drug of Abuse (DOA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug of Abuse (DOA) Testing Breakdown Data by Type
4.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Type (2019-2024)
4.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2025-2030)
5 Drug of Abuse (DOA) Testing Breakdown Data by Application
5.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Application (2019-2024)
5.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug of Abuse (DOA) Testing Market Size (2019-2030)
6.2 North America Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
6.4 North America Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug of Abuse (DOA) Testing Market Size (2019-2030)
7.2 Europe Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
7.4 Europe Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size (2019-2030)
8.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug of Abuse (DOA) Testing Market Size (2019-2030)
9.2 Latin America Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
9.4 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size (2019-2030)
10.2 Middle East & Africa Drug of Abuse (DOA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Siemens
11.1.1 Siemens Company Detail
11.1.2 Siemens Business Overview
11.1.3 Siemens Drug of Abuse (DOA) Testing Introduction
11.1.4 Siemens Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.1.5 Siemens Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Drug of Abuse (DOA) Testing Introduction
11.2.4 Merck Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Drug of Abuse (DOA) Testing Introduction
11.3.4 Roche Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Bio-Rad
11.5.1 Bio-Rad Company Detail
11.5.2 Bio-Rad Business Overview
11.5.3 Bio-Rad Drug of Abuse (DOA) Testing Introduction
11.5.4 Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.5.5 Bio-Rad Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Drug of Abuse (DOA) Testing Introduction
11.6.4 Abbott Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Detail
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Introduction
11.7.4 Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.7.5 Quest Diagnostics Recent Development
11.8 Psychemedics
11.8.1 Psychemedics Company Detail
11.8.2 Psychemedics Business Overview
11.8.3 Psychemedics Drug of Abuse (DOA) Testing Introduction
11.8.4 Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2019-2024)
11.8.5 Psychemedics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
